so likely to be a heap of cheap shares coming up in the next few weeks. For long-term holders this is an excellent opportunity to top up and average down. Nothing changes
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025